Sun Pharma Advanced Research Company Limited Share Price & Analysis
₹224.52▼ -1.31%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹224.52
-1.31%
Open
₹—
High
₹229.22
Low
₹221.55
Close
₹224.52
52W High
₹289
52W Low
₹108
Volume
1325K
Lot Size
1
Sector
Healthcare
Market Cap
₹8K Cr
Face Value
₹1
Mid Cap
Price Chart
Fundamentals
P/E
4.88
Sector P/E
54.4
P/B
4.95
EPS
₹47.86
ROE
279%
ROCE
164%
D/E Ratio
0.42
Div Yield
0%
Book Value
₹41.3
+
Strengths
- ✓Excellent return on equity (ROE 279%)
- ✓Efficient capital deployment (ROCE 164%)
- ✓Attractively valued vs sector (P/E 4.9x vs industry 54.4x)
- ✓Low debt relative to equity (D/E 0.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SPARC · as of May 2026
Promoters65.67%▼0.01
FII1.47%▲0.02
DII0.97%▼0.16
Public31.88%▲0.12
| Category | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | May 2026 |
|---|---|---|---|---|---|---|
| Promoters | 65.68% | 65.68% | 65.68% | 65.68% | 65.68% | 65.67% |
| FII | 3.24% | 2.64% | 2.15% | 2.23% | 1.45% | 1.47% |
| DII | 0.67% | 0.17% | 0.21% | 0.64% | 1.13% | 0.97% |
| Public | 30.41% | 31.51% | 31.96% | 31.47% | 31.76% | 31.88% |
Latest News
All news →Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.9K Cr ▲23062.5% | ₹8 Cr ▲0.0% | ₹8 Cr ▼20.0% | ₹10 Cr ▼63.0% | ₹27 Cr ▲80.0% | ₹15 Cr ▲15.4% | ₹13 Cr ▼23.5% | ₹17 Cr |
| Op. Profit | ₹1.8K Cr ▲3210.5% | ₹-57 Cr ▲13.6% | ₹-66 Cr ▼26.9% | ₹-52 Cr ▲1.9% | ₹-53 Cr ▲28.4% | ₹-74 Cr ▲28.2% | ₹-103 Cr ▼10.8% | ₹-93 Cr |
| OPM | 96.0% ▲114.3% | -670.0% ▲19.9% | -836.0% ▼54.8% | -540.0% ▼175.5% | -196.0% ▲60.3% | -494.0% ▲38.3% | -800.0% ▼44.1% | -555.0% |
| Net Profit | ₹1.8K Cr ▲2301.3% | ₹-80 Cr ▼5.3% | ₹-76 Cr ▼46.2% | ₹-52 Cr ▲13.3% | ₹-60 Cr ▲25.0% | ₹-80 Cr ▲25.2% | ₹-107 Cr ▼11.5% | ₹-96 Cr |
| EPS (₹) | 54.27 ▲2288.3% | -2.48 ▼6.0% | -2.34 ▼46.2% | -1.6 ▲13.0% | -1.84 ▲24.9% | -2.45 ▲26.0% | -3.31 ▼11.8% | -2.96 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹1.9K Cr ▲2509.7% | ₹72 Cr ▼5.3% | ₹76 Cr ▼68.2% | ₹239 Cr |
| Expenses | ₹280 Cr ▼29.1% | ₹395 Cr ▼17.4% | ₹478 Cr ▲5.5% | ₹453 Cr |
| Op. Profit | ₹1.6K Cr ▲595.0% | ₹-323 Cr ▲19.7% | ₹-402 Cr ▼87.9% | ₹-214 Cr |
| OPM | 85.0% ▲118.9% | -450.0% ▲15.4% | -532.0% ▼491.1% | -90.0% |
| Other Income | ₹-1 Cr ▼150.0% | ₹2 Cr ▼93.1% | ₹29 Cr ▲163.6% | ₹11 Cr |
| Interest | ₹34 Cr ▲277.8% | ₹9 Cr ▲350.0% | ₹2 Cr ▼75.0% | ₹8 Cr |
| Depreciation | ₹10 Cr ▼16.7% | ₹12 Cr ▼7.7% | ₹13 Cr ▲8.3% | ₹12 Cr |
| PBT | ₹1.6K Cr ▲552.8% | ₹-343 Cr ▲11.4% | ₹-387 Cr ▼73.5% | ₹-223 Cr |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | ₹1.6K Cr ▲552.8% | ₹-343 Cr ▲11.4% | ₹-387 Cr ▼73.5% | ₹-223 Cr |
| EPS (₹) | 47.86 ▲553.6% | -10.55 ▲11.6% | -11.93 ▼73.9% | -6.86 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Liabilities | ||||
| Equity Capital | ₹32 Cr ▲0.0% | ₹32 Cr ▲0.0% | ₹32 Cr ▲0.0% | ₹32 Cr |
| Reserves | ₹1.3K Cr ▲624.5% | ₹-249 Cr ▼367.7% | ₹93 Cr ▼80.6% | ₹480 Cr |
| Borrowings | ₹559 Cr ▲107.8% | ₹269 Cr ▲341.0% | ₹61 Cr ▲281.3% | ₹16 Cr |
| Other Liabilities | ₹273 Cr ▼3.9% | ₹284 Cr ▼13.4% | ₹328 Cr ▲8.6% | ₹302 Cr |
| Total Liabilities | ₹2.2K Cr ▲546.1% | ₹336 Cr ▼34.8% | ₹515 Cr ▼38.0% | ₹830 Cr |
| Assets | ||||
| Fixed Assets | ₹157 Cr ▲58.6% | ₹99 Cr ▼8.3% | ₹108 Cr ▲1.9% | ₹106 Cr |
| CWIP | ₹0 Cr ▼100.0% | ₹54 Cr ▲22.7% | ₹44 Cr ▲63.0% | ₹27 Cr |
| Investments | ₹0 Cr | ₹0 Cr ▼100.0% | ₹2 Cr ▼99.3% | ₹291 Cr |
| Other Assets | ₹2.0K Cr ▲1000.5% | ₹183 Cr ▼49.4% | ₹362 Cr ▼10.8% | ₹406 Cr |
| Total Assets | ₹2.2K Cr ▲546.1% | ₹336 Cr ▼34.8% | ₹515 Cr ▼38.0% | ₹830 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating CF | ₹-239 Cr ▲33.6% | ₹-360 Cr ▲16.1% | ₹-429 Cr ▼521.7% | ₹-69 Cr |
| Investing CF | ₹-24 Cr ▼115.2% | ₹158 Cr ▼59.7% | ₹392 Cr ▲171.5% | ₹-548 Cr |
| Financing CF | ₹261 Cr ▲31.2% | ₹199 Cr ▲373.8% | ₹42 Cr ▼93.2% | ₹617 Cr |
| Net Cash Flow | ₹-1 Cr ▲66.7% | ₹-3 Cr ▼160.0% | ₹5 Cr ▲600.0% | ₹-1 Cr |
| Free Cash Flow | ₹-262 Cr ▲29.2% | ₹-370 Cr ▲18.7% | ₹-455 Cr ▼441.7% | ₹-84 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Debtor Days | 2d ▼97.6% | 82d ▲9.3% | 75d ▲50.0% | 50d |
| Inventory Days | — | — | — | — |
| Days Payable | — | — | — | — |
| Cash Conv. Cycle | 2d ▼97.6% | 82d ▲9.3% | 75d ▲50.0% | 50d |
| Working Capital Days | 215d ▲112.1% | -1780d ▼141.2% | -738d ▼282.4% | -193d |
| ROCE | 164.0% ▲158.8% | -279.0% ▼158.3% | -108.0% | — |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Sun Pharma Advanced Research Company Limited share price today?▾
Sun Pharma Advanced Research Company Limited (SPARC) is currently trading at ₹224.52 on NSE, down 1.31% as of the last market session. Prices update daily after market close on MarketNetra.
Is Sun Pharma Advanced Research Company Limited available in F&O (Futures & Options)?▾
Yes, Sun Pharma Advanced Research Company Limited (SPARC) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Sun Pharma Advanced Research Company Limited 52-week high and low?▾
Sun Pharma Advanced Research Company Limited's 52-week high is ₹289 and the 52-week low is ₹108. The current price of ₹224.52 is 22.3% below the 52W high.
What is Sun Pharma Advanced Research Company Limited P/E ratio?▾
Sun Pharma Advanced Research Company Limited's current P/E ratio is 4.88. This indicates the market is paying ₹4.88 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Sun Pharma Advanced Research Company Limited options?▾
Sun Pharma Advanced Research Company Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade SPARC options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.